APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intelligent Pills

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Intelligent Pills Market Outlook and Growth Opportunities 2026

Report ID 174003720420 December 2025197 pages

Choose your research edition.

Industry ResearchIntelligent Pills Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Intelligent Pills Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Intelligent Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intelligent Pills Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Intelligent Pills Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Intelligent Pills market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Intelligent Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intelligent Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intelligent Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Intelligent Pills market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Intelligent Pills market include CapsoVision, Given Imaging, Lloyds Pharmacy, Medimetrics and Proteus Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intelligent Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intelligent Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intelligent Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intelligent Pills market size, projected growth trends, production technologies, key applications, and end-use industries.

Intelligent Pills Segment by Company

CapsoVision

Given Imaging

Lloyds Pharmacy

Medimetrics

Proteus Biomedical

Intelligent Pills Segment by Type

Heart Rate Monitoring

Temperature Monitoring

Respiratory Monitoring

Intelligent Pills Segment by Application

Reflux Monitoring

Capsule Endoscopy

Sleeping Disorders

Stress Management

Mobility Monitoring

Others

Intelligent Pills Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Intelligent Pills status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intelligent Pills market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intelligent Pills significant trends, drivers, influence factors in global and regions.

6. To analyze Intelligent Pills competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intelligent Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intelligent Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intelligent Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intelligent Pills market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intelligent Pills industry.

Chapter 3: Detailed analysis of Intelligent Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intelligent Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intelligent Pills in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intelligent Pills Industry Trends Table 2. Intelligent Pills Industry Drivers Table 3. Intelligent Pills Industry Opportunities and Challenges Table 4. Intelligent Pills Industry Restraints Table 5. Global Intelligent Pills Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intelligent Pills Revenue Share by Company (2021-2026) Table 7. Global Intelligent Pills Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Intelligent Pills Sales Volume Share by Company (2021-2026) Table 9. Global Intelligent Pills Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Intelligent Pills Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intelligent Pills Key Company Manufacturing Base & Headquarters Table 12. Global Intelligent Pills Company, Product Type & Application Table 13. Global Intelligent Pills Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intelligent Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Heart Rate Monitoring Table 18. Significant Companies of Temperature Monitoring Table 19. Significant Companies of Respiratory Monitoring Table 20. Global Intelligent Pills Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Intelligent Pills Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Intelligent Pills Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Intelligent Pills Sales Volume Share by Type (2021-2026) Table 24. Global Intelligent Pills Sales Volume Share by Type (2027-2032) Table 25. Global Intelligent Pills Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Intelligent Pills Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Intelligent Pills Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Intelligent Pills Sales Value Share by Type (2021-2026) Table 29. Global Intelligent Pills Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Reflux Monitoring Table 31. Significant Companies of Capsule Endoscopy Table 32. Significant Companies of Sleeping Disorders Table 33. Significant Companies of Stress Management Table 34. Significant Companies of Mobility Monitoring Table 35. Significant Companies of Others Table 36. Global Intelligent Pills Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Intelligent Pills Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Intelligent Pills Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Intelligent Pills Sales Volume Share by Application (2021-2026) Table 40. Global Intelligent Pills Sales Volume Share by Application (2027-2032) Table 41. Global Intelligent Pills Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Intelligent Pills Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Intelligent Pills Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Intelligent Pills Sales Value Share by Application (2021-2026) Table 45. Global Intelligent Pills Sales Value Share by Application (2027-2032) Table 46. Global Intelligent Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Intelligent Pills Sales by Region (2021-2026) & (K Units) Table 48. Global Intelligent Pills Sales Market Share by Region (2021-2026) Table 49. Global Intelligent Pills Sales by Region (2027-2032) & (K Units) Table 50. Global Intelligent Pills Sales Market Share by Region (2027-2032) Table 51. Global Intelligent Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Intelligent Pills Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Intelligent Pills Sales Value Share by Region (2021-2026) Table 54. Global Intelligent Pills Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Intelligent Pills Sales Value Share by Region (2027-2032) Table 56. Global Intelligent Pills Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Intelligent Pills Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Intelligent Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Intelligent Pills Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Intelligent Pills Sales by Country (2021-2026) & (K Units) Table 61. Global Intelligent Pills Sales Market Share by Country (2021-2026) Table 62. Global Intelligent Pills Sales by Country (2027-2032) & (K Units) Table 63. Global Intelligent Pills Sales Market Share by Country (2027-2032) Table 64. Global Intelligent Pills Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Intelligent Pills Sales Value Market Share by Country (2021-2026) Table 66. Global Intelligent Pills Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Intelligent Pills Sales Value Market Share by Country (2027-2032) Table 68. CapsoVision Company Information Table 69. CapsoVision Business Overview Table 70. CapsoVision Intelligent Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. CapsoVision Intelligent Pills Product Portfolio Table 72. CapsoVision Recent Development Table 73. Given Imaging Company Information Table 74. Given Imaging Business Overview Table 75. Given Imaging Intelligent Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Given Imaging Intelligent Pills Product Portfolio Table 77. Given Imaging Recent Development Table 78. Lloyds Pharmacy Company Information Table 79. Lloyds Pharmacy Business Overview Table 80. Lloyds Pharmacy Intelligent Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Lloyds Pharmacy Intelligent Pills Product Portfolio Table 82. Lloyds Pharmacy Recent Development Table 83. Medimetrics Company Information Table 84. Medimetrics Business Overview Table 85. Medimetrics Intelligent Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Medimetrics Intelligent Pills Product Portfolio Table 87. Medimetrics Recent Development Table 88. Proteus Biomedical Company Information Table 89. Proteus Biomedical Business Overview Table 90. Proteus Biomedical Intelligent Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Proteus Biomedical Intelligent Pills Product Portfolio Table 92. Proteus Biomedical Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Intelligent Pills Distributors List Table 96. Intelligent Pills Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Intelligent Pills Product Image Figure 2. Global Intelligent Pills Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intelligent Pills Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intelligent Pills Sales (2021-2032) & (K Units) Figure 5. Global Intelligent Pills Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Intelligent Pills Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Heart Rate Monitoring Image Figure 10. Temperature Monitoring Image Figure 11. Respiratory Monitoring Image Figure 12. Global Intelligent Pills Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Intelligent Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Intelligent Pills Sales Volume Share by Type (2021-2032) Figure 15. Global Intelligent Pills Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Intelligent Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Intelligent Pills Sales Value Share by Type (2021-2032) Figure 18. Reflux Monitoring Image Figure 19. Capsule Endoscopy Image Figure 20. Sleeping Disorders Image Figure 21. Stress Management Image Figure 22. Mobility Monitoring Image Figure 23. Others Image Figure 24. Global Intelligent Pills Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Intelligent Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Intelligent Pills Sales Volume Share by Application (2021-2032) Figure 27. Global Intelligent Pills Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Intelligent Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Intelligent Pills Sales Value Share by Application (2021-2032) Figure 30. Global Intelligent Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Intelligent Pills Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Intelligent Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Intelligent Pills Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Intelligent Pills Sales Value (2021-2032) & (US$ Million) Figure 35. North America Intelligent Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Intelligent Pills Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Intelligent Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Intelligent Pills Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Intelligent Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Intelligent Pills Sales Value (2021-2032) & (US$ Million) Figure 41. South America Intelligent Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Intelligent Pills Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Intelligent Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Intelligent Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Intelligent Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Intelligent Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Intelligent Pills Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Intelligent Pills Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Heart Rate Monitoring
  • Temperature Monitoring
  • Respiratory Monitoring
Applications
  • Reflux Monitoring
  • Capsule Endoscopy
  • Sleeping Disorders
  • Stress Management
  • Mobility Monitoring
  • Others
Companies covered
  • CapsoVision
  • Given Imaging
  • Lloyds Pharmacy
  • Medimetrics
  • Proteus Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intelligent Pills Sales Value (2021-2032)
  4. 1.2.2 Global Intelligent Pills Sales Volume (2021-2032)
  5. 1.2.3 Global Intelligent Pills Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intelligent Pills Market Dynamics
  1. 2.1 Intelligent Pills Industry Trends
  2. 2.2 Intelligent Pills Industry Drivers
  3. 2.3 Intelligent Pills Industry Opportunities and Challenges
  4. 2.4 Intelligent Pills Industry Restraints
3 Intelligent Pills Market by Company
  1. 3.1 Global Intelligent Pills Company Revenue Ranking in 2025
  2. 3.2 Global Intelligent Pills Revenue by Company (2021-2026)
  3. 3.3 Global Intelligent Pills Sales Volume by Company (2021-2026)
  4. 3.4 Global Intelligent Pills Average Price by Company (2021-2026)
  5. 3.5 Global Intelligent Pills Company Ranking (2024-2026)
  6. 3.6 Global Intelligent Pills Company Manufacturing Base and Headquarters
  7. 3.7 Global Intelligent Pills Company Product Type and Application
  8. 3.8 Global Intelligent Pills Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intelligent Pills Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intelligent Pills Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intelligent Pills Market by Type
  1. 4.1 Intelligent Pills Type Introduction
  2. 4.1.1 Heart Rate Monitoring
  3. 4.1.2 Temperature Monitoring
  4. 4.1.3 Respiratory Monitoring
  5. 4.2 Global Intelligent Pills Sales Volume by Type
  6. 4.2.1 Global Intelligent Pills Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Intelligent Pills Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Intelligent Pills Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Intelligent Pills Sales Value by Type
  10. 4.3.1 Global Intelligent Pills Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Intelligent Pills Sales Value by Type (2021-2032)
  12. 4.3.3 Global Intelligent Pills Sales Value Share by Type (2021-2032)
5 Intelligent Pills Market by Application
  1. 5.1 Intelligent Pills Application Introduction
  2. 5.1.1 Reflux Monitoring
  3. 5.1.2 Capsule Endoscopy
  4. 5.1.3 Sleeping Disorders
  5. 5.1.4 Stress Management
  6. 5.1.5 Mobility Monitoring
  7. 5.1.6 Others
  8. 5.2 Global Intelligent Pills Sales Volume by Application
  9. 5.2.1 Global Intelligent Pills Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Intelligent Pills Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Intelligent Pills Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Intelligent Pills Sales Value by Application
  13. 5.3.1 Global Intelligent Pills Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Intelligent Pills Sales Value by Application (2021-2032)
  15. 5.3.3 Global Intelligent Pills Sales Value Share by Application (2021-2032)
6 Intelligent Pills Regional Sales and Value Analysis
  1. 6.1 Global Intelligent Pills Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intelligent Pills Sales by Region (2021-2032)
  3. 6.2.1 Global Intelligent Pills Sales by Region: 2021-2026
  4. 6.2.2 Global Intelligent Pills Sales by Region (2027-2032)
  5. 6.3 Global Intelligent Pills Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intelligent Pills Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intelligent Pills Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intelligent Pills Sales Value by Region (2027-2032)
  9. 6.5 Global Intelligent Pills Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intelligent Pills Sales Value (2021-2032)
  12. 6.6.2 North America Intelligent Pills Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intelligent Pills Sales Value (2021-2032)
  15. 6.7.2 Europe Intelligent Pills Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intelligent Pills Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intelligent Pills Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intelligent Pills Sales Value (2021-2032)
  21. 6.9.2 South America Intelligent Pills Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intelligent Pills Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intelligent Pills Sales Value Share by Country, 2025 VS 2032
7 Intelligent Pills Country-level Sales and Value Analysis
  1. 7.1 Global Intelligent Pills Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intelligent Pills Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intelligent Pills Sales by Country (2021-2032)
  4. 7.3.1 Global Intelligent Pills Sales by Country (2021-2026)
  5. 7.3.2 Global Intelligent Pills Sales by Country (2027-2032)
  6. 7.4 Global Intelligent Pills Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intelligent Pills Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intelligent Pills Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intelligent Pills Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intelligent Pills Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intelligent Pills Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intelligent Pills Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intelligent Pills Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intelligent Pills Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intelligent Pills Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intelligent Pills Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intelligent Pills Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intelligent Pills Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intelligent Pills Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intelligent Pills Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intelligent Pills Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intelligent Pills Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intelligent Pills Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intelligent Pills Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intelligent Pills Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intelligent Pills Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intelligent Pills Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intelligent Pills Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intelligent Pills Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intelligent Pills Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intelligent Pills Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intelligent Pills Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intelligent Pills Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intelligent Pills Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intelligent Pills Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intelligent Pills Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intelligent Pills Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intelligent Pills Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intelligent Pills Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CapsoVision
  2. 8.1.1 CapsoVision Company Information
  3. 8.1.2 CapsoVision Business Overview
  4. 8.1.3 CapsoVision Intelligent Pills Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CapsoVision Intelligent Pills Product Portfolio
  6. 8.1.5 CapsoVision Recent Developments
  7. 8.2 Given Imaging
  8. 8.2.1 Given Imaging Company Information
  9. 8.2.2 Given Imaging Business Overview
  10. 8.2.3 Given Imaging Intelligent Pills Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Given Imaging Intelligent Pills Product Portfolio
  12. 8.2.5 Given Imaging Recent Developments
  13. 8.3 Lloyds Pharmacy
  14. 8.3.1 Lloyds Pharmacy Company Information
  15. 8.3.2 Lloyds Pharmacy Business Overview
  16. 8.3.3 Lloyds Pharmacy Intelligent Pills Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lloyds Pharmacy Intelligent Pills Product Portfolio
  18. 8.3.5 Lloyds Pharmacy Recent Developments
  19. 8.4 Medimetrics
  20. 8.4.1 Medimetrics Company Information
  21. 8.4.2 Medimetrics Business Overview
  22. 8.4.3 Medimetrics Intelligent Pills Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Medimetrics Intelligent Pills Product Portfolio
  24. 8.4.5 Medimetrics Recent Developments
  25. 8.5 Proteus Biomedical
  26. 8.5.1 Proteus Biomedical Company Information
  27. 8.5.2 Proteus Biomedical Business Overview
  28. 8.5.3 Proteus Biomedical Intelligent Pills Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Proteus Biomedical Intelligent Pills Product Portfolio
  30. 8.5.5 Proteus Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intelligent Pills Value Chain Analysis
  2. 9.1.1 Intelligent Pills Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intelligent Pills Sales Mode & Process
  6. 9.2 Intelligent Pills Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intelligent Pills Distributors
  9. 9.2.3 Intelligent Pills Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst